From the beginning of the Pandemic @Survivor_Corps has led the way.
A few examples:
- Kicked off plasma movement in early 2020 (we saved hospitals and blood bankers a fortune b/c they never had to advertise. We did it for them)
1/
- Provided free and immediate access to Monoclonal Antibodies and other early Therapeutics through our portal GotCOVID.org (we did it way better and waaay faster than the US Government - they agreed)
2/
- Advised White House / CDC / HHS / NIH / Congress etc etc (all unpaid except for one HHS contract - Health Plus)
- Linked every major media outlet (and all the small ones too) with real people to tell their COVID stories (we basically act as unpaid bookers)
3/
News of the study was welcomed by patients and advocacy groups.
“We have been clamoring for Paxlovid to be trialed, and it’s about time,” said Diana Güthe, the founder of a long COVID support group called Survivor Corps." 1/ thereporter.com/2022/11/21/cou…
"Starting “in winter 2021, we noticed many long COVID patients experiencing a degree of symptom relief after vaccination, indicating there was viral persistence.”
2/
"The Stanford trial represents just the beginning of what should be a broader search for long COVID therapies, said Güthe."
3/
"Diana Güthe, is founder of SurvivorCorps, a grassroots community to help long-COVID survivors and doctors find answers." 1/ ktvu.com/news/stanford-…
"She says she is encouraged that there is attention to long COVID research, which she and others have called for through their advocacy group.
"I had one of the first confirmed cases of COVID in the country in early March 2020," said Güthe."
2/
"She says after she got better, though, some symptoms didn't go away, "I had what I call a relapsing remitting case of long COVID They came and went for several months and lasted about up to a year. "
3/
(1) cold and flu-like symptoms (2) change in smell and/or taste (3) dyspnea and chest pain (4) cognitive and visual problems (5) cardiac symptoms
Who was at risk for #LongCovid? Just about everyone.
"Initial COVID-19 symptom presentation varies; however, the development of PASC appears to be independent of COVID-19 symptom presentation, severity, or the presence of pre-morbid (pre-existing) health conditions."